REQUEST A DEMO
Total
USD $0.00
Search more companies

Disfarma Gc Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Disfarma Gc Sas Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Disfarma Gc Sas is based in Colombia, with the head office in Giron. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Disfarma Gc Sas was incorporated on September 09, 2009. 1,592 (2024) employees currently work for Disfarma Gc Sas. The company’s latest financial report indicates a net sales revenue increase of 31.21% in 2023. Its’ total assets recorded a growth of 23.99%. In 2023, Disfarma Gc Sas’s net profit margin increased by 0.26%.

Headquarters
Centro Logistico San Jorge Kilometro 7 - 400 Anillo Via Palenque Diagonal Floridablanca # 22 - 31 Bodega 89
Giron; Santander;

Contact Details: Purchase the Disfarma Gc Sas report to view the information.

Website: http://www.disfarma.com.co

Basic Information
Total Employees:
Purchase the Disfarma Gc Sas report to view the information.
Outstanding Shares:
Purchase the Disfarma Gc Sas report to view the information.
Incorporation Date:
September 09, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Disfarma Gc Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.21%
Total operating revenue
31.21%
Operating profit (EBIT)
19.17%
Net Profit (Loss) for the Period
42.24%
Total assets
23.99%
Total equity
27.99%
Operating Profit Margin (ROS)
-0.41%
Net Profit Margin
0.26%
Return on Equity (ROE)
2.13%
Debt to Equity Ratio
3.01%
Quick Ratio
0.2%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?